What it does
Accelerate the development and uptake of innovation into the NHS by;
- Supporting innovators to determine whether the innovation matches a need and how wide spread that need might be.
- Where further product development is necessary, signpost innovators to appropriate resources along the development pathway including finance.
- Supporting innovators to understand the real world impact of their innovation for the NHS.
- Assessing and advising on scale up plans when innovations have achieved initial uptake.
They provide a broad range of support to companies, and input into policy development. They will help companies to navigate the NHS, prepare for scale-up and gather the evidence they need. They support adoption and spread for prioritised innovations.
What it doesn't do
AHSNs are not sales offices. Their primary focus is not to provide sales leads or introductions. AHSNs are NHS bodies, but they are not users or buyers of clinical products.
Data is shared across the 15 AHSNs. They understand the need for commercial confidentiality but need to be able to share information across the 15 AHSNs and the NHS to effectively support the development and uptake of innovation.
Information you submit will be reviewed within 30 days. You may be initially contacted to better understand the support you need.